Highbridge Capital Management LLC Bio Line Rx Ltd. Call Options Transaction History
Highbridge Capital Management LLC
- $435 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLRX
# of Institutions
27Shares Held
2.54MCall Options Held
75.1KPut Options Held
5.1K-
Cvi Holdings, LLC Wilmington, DE816KShares$2.71 Million4.05% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY94.1KShares$312,5210.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC92KShares$305,4400.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA87.2KShares$289,5530.0% of portfolio
-
Morgan Stanley New York, NY79.1KShares$262,6180.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $204M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...